Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 3,540 Ptc Therapeutics, Inc. shares (Form 4)

Traded May 8, 2026 · Filed May 12, 2026

On May 8, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 3,540 Ptc Therapeutics, Inc. shares at an average US$78.97 for US$280K under a trading plan, leaving 105,212 shares. Filed May 12, 2026 (Form 4).

Sold
3,540 shares
Price
US$78.97 average (US$78.00 to US$79.31)
Value
US$280K
Holding after
105,212 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 8, 2026Common StockOption exercise2,740US$46.54107,952Direct
May 8, 2026Common StockSale840US$78.23107,112Direct
May 8, 2026Common StockSale1,900US$79.31105,212Direct
May 8, 2026Common StockOption exercise800US$46.54106,012Direct
May 8, 2026Common StockSale200US$78.00105,812Direct
May 8, 2026Common StockSale600US$79.28105,212Direct

Source

View original at SEC

Related